China NMPA Innovation Pathway Document List


In December 2018, China's National Medical Products Administration (NMPA) released the Special Medical Device Special Review Procedure (No. 83 of 2018), as part of their efforts to encourage innovation in medical device research and development. This revision to the"Innovative Medical Device Special Review Procedures" will abolish the previous "Special Approval Procedure for Innovative Medical Devices (Trial)" (Food and Drug Administration [2014] No. 13).

ARQon has summarised the submission document list for easy reference. Check out the following link for the document list:

-China NMPA Innovation Pathway Document List

Contact us at info@arqon.com.


Recent Posts
Categories